Authors:
GRATAMA JW
VANDERLINDEN R
DEVRIES W
DEVELD J
LEVIN MD
SINTNICOLAAS K
VANTVEER MB
BOLHUIS RLH
Citation: Jw. Gratama et al., SIMULTANEOUS DETECTION OF IGM AND IGG ANTIBODIES AGAINST PLATELETS, LYMPHOCYTES, AND GRANULOCYTES BY FLOW-CYTOMETRY, Infusionstherapie und Transfusionsmedizin, 25(5), 1998, pp. 317-324
Authors:
BOLHUIS RLH
STOTER G
LAMERS CHJ
WILLEMSEN RA
GRATAMA JW
WEIJTENS MEM
Citation: Rlh. Bolhuis et al., A PHASE I II STUDY OF THE SAFETY OF AUTOLOGOUS GENE MODIFIED T-LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL-CANCER/, The FASEB journal, 12(4), 1998, pp. 1679-1679
Authors:
GRATAMA JW
ORFAO A
BARNETT D
BRANDO B
HUBER A
JANOSSY G
JOHNSEN HE
KEENEY M
MARTI GE
PREIJERS F
ROTHE G
SERKE S
SUTHERLAND DR
VANDERSCHOOT CE
SCHMITZ G
PAPA S
Citation: Jw. Gratama et al., FLOW CYTOMETRIC ENUMERATION OF CD34(+) HEMATOPOIETIC STEM AND PROGENITOR CELLS, Cytometry, 34(3), 1998, pp. 128-142
Authors:
SCHWARTZ A
MARTI GE
POON R
GRATAMA JW
FERNANDEZREPOLLET E
Citation: A. Schwartz et al., STANDARDIZING FLOW-CYTOMETRY - A CLASSIFICATION-SYSTEM OF FLUORESCENCE STANDARDS USED FOR FLOW-CYTOMETRY, Cytometry, 33(2), 1998, pp. 106-114
Authors:
GRATAMA JW
DHAUTCOURT JL
MANDY F
ROTHE G
BARNETT D
JANOSSY G
PAPA S
SCHMITZ G
LENKEI R
Citation: Jw. Gratama et al., FLOW CYTOMETRIC QUANTITATION OF IMMUNOFLUORESCENCE INTENSITY - PROBLEMS AND PERSPECTIVES, Cytometry, 33(2), 1998, pp. 166-178
Citation: Apa. Gadisseur et al., EXPRESSION OF THE T-CELL ACTIVATION ANTIGEN CD134 (OX40) DOES NOT PREDICT ACUTE-GRAFT-VERSUS-HOST DISEASE IN T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 102(1), 1998, pp. 213-213
Authors:
KRUIT WHJ
GOEY SH
LAMERS CHJ
GRATAMA JW
VISSER B
SCHMITZ PIM
EGGERMONT AMM
BOLHUIS RLH
STOTER G
Citation: Whj. Kruit et al., HIGH-DOSE REGIMEN OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN COMBINATION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC RENAL-CELL-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 312-320
Citation: Acm. Kroes et al., RAPID OCCURRENCE OF LYMPHOPROLIFERATIVE DISEASE AFTER PANCREAS-KIDNEYTRANSPLANTATION PERFORMED DURING ACUTE PRIMARY EPSTEIN-BARR-VIRUS INFECTION, Clinical infectious diseases, 24(3), 1997, pp. 339-343
Authors:
BOLHUIS RLH
STOTER G
LAMERS CHJ
WILLEMSEN RA
GRATAMA JW
WEIJTENS MEM
Citation: Rlh. Bolhuis et al., A PHASE-I STUDY OF THE SAFETY OF AUTOLOGOUS GENE MODIFIED T-LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL-CANCER, Cancer gene therapy, 4(5), 1997, pp. 335-335
Authors:
GRATAMA JW
KRAAN J
VANDENBEEMD R
HOOIBRINK B
VANBOCKSTAELE DR
HOOIJKAAS H
Citation: Jw. Gratama et al., ANALYSIS OF VARIATION IN RESULTS OF FLOW CYTOMETRIC LYMPHOCYTE IMMUNOPHENOTYPING IN A MULTICENTER STUDY, Cytometry, 30(4), 1997, pp. 166-177
Authors:
GRATAMA JW
KRAAN J
LEVERING W
VANBOCKSTAELE DR
RIJKERS GT
VANDERSCHOOT CE
Citation: Jw. Gratama et al., ANALYSIS OF VARIATION IN RESULTS OF CD34(-CELL ENUMERATION IN A MULTICENTER STUDY() HEMATOPOIETIC PROGENITOR), Cytometry, 30(3), 1997, pp. 109-117
Authors:
GRATAMA JW
KRAAN J
ADRIAANSEN H
HOOIBRINK B
LEVERING W
REINDERS P
VANDENBEEMD MWM
VANDERHOLT B
BOLHUIS RLH
Citation: Jw. Gratama et al., REDUCTION OF INTERLABORATORY VARIABILITY IN FLOW CYTOMETRIC IMMUNOPHENOTYPING BY STANDARDIZATION OF INSTRUMENT SET-UP AND CALIBRATION, AND STANDARD LIST MODE DATA-ANALYSIS, Cytometry, 30(1), 1997, pp. 10-22
Authors:
GRATAMA JW
VANDERLINDEN R
VANDERHOLT B
BOLHUIS RLH
VANDEWINKEL JGJ
Citation: Jw. Gratama et al., ANALYSIS OF FACTORS CONTRIBUTING TO THE FORMATION OF MONONUCLEAR CELLAGGREGATES (ESCAPEES) IN FLOW CYTOMETRIC IMMUNOPHENOTYPING, Cytometry, 29(3), 1997, pp. 250-260
Authors:
LAMERS CHJ
BOLHUIS RLH
WARNAAR SO
STOTER G
GRATAMA JW
Citation: Chj. Lamers et al., LOCAL BUT NO SYSTEMIC IMMUNOMODULATION BY INTRAPERITONEAL TREATMENT OF ADVANCED OVARIAN-CANCER WITH AUTOLOGOUS T-LYMPHOCYTES RE-TARGETED BYA BI-SPECIFIC MONOCLONAL-ANTIBODY, International journal of cancer, 73(2), 1997, pp. 211-219
Authors:
DEGREEF GE
DEWINTER F
LUYTEN A
GRATAMA JW
VANTVEER MB
Citation: Ge. Degreef et al., HIGH-DOSE CYCLOFOSFAMIDE IS NOT SUPERIOR TO OTHER CHEMOTHERAPY SCHEDULES WITH RESPECT TO THEIR MOBILIZING CAPACITY, Blood, 90(10), 1997, pp. 4209-4209
Authors:
SANDVEJ K
GRATAMA JW
MUNCH M
ZHOU XG
BOLHUIS RLH
ANDRESEN BS
GREGERSEN N
HAMILTONDUTOIT S
Citation: K. Sandvej et al., SEQUENCE-ANALYSIS OF THE EPSTEIN-BARR-VIRUS (EBV) LATENT MEMBRANE PROTEIN-1 GENE AND PROMOTER REGION - IDENTIFICATION OF 4 VARIANTS AMONG WILD-TYPE EBV ISOLATES, Blood, 90(1), 1997, pp. 323-330
Authors:
BEUN GDM
VLASVELD LT
BOT F
GRATAMA JW
SLINGERLAND R
VANTVEER MB
Citation: Gdm. Beun et al., LOW-DOSE RIL-2-INDUCED REMISSION OF DISSEMINATED CD30(-CELL LYMPHOMA THROUGH REINFORCEMENT OF PRESUMED T-CELL-MEDIATED TUMOR-CELL KILLING, COMPLICATED BY UNILATERAL DROWNING OF LYMPHOMA-INFILTRATED LUNG() ANAPLASTIC LARGE), Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 162-167
Citation: A. Schwartz et al., STANDARDIZING FLOW-CYTOMETRY - CONSTRUCTION OF A STANDARDIZED FLUORESCENCE CALIBRATION PLOT USING MATCHING SPECTRAL CALIBRATORS, Cytometry, 26(1), 1996, pp. 22-31
Authors:
GRATAMA JW
SCHMITZ PIM
GOEY SH
LAMERS CHJ
STOTER G
BOLHUIS RLH
Citation: Jw. Gratama et al., MODULATION OF IMMUNE PARAMETERS IN PATIENTS WITH METASTATIC RENAL-CELL CANCER RECEIVING COMBINATION IMMUNOTHERAPY (IL-2, IFN-ALPHA AND AUTOLOGOUS IL-2-ACTIVATED LYMPHOCYTES), International journal of cancer, 65(2), 1996, pp. 152-160
Authors:
KLUINNELEMANS JC
VANWERING ER
VANTVEER MB
VANDERSCHOOT CE
ADRIAANSEN HJ
VANDERBURGH FJ
GRATAMA JW
Citation: Jc. Kluinnelemans et al., PITFALLS IN THE IMMUNOPHENOTYPING OF LEUKEMIA AND LEUKEMIC LYMPHOMAS - SURVEY OF 9 YEARS OF QUALITY-CONTROL IN THE NETHERLANDS, British Journal of Haematology, 95(4), 1996, pp. 692-699
Authors:
KRUIT WHJ
PUNT CJA
GOEY SH
DEMULDER PHM
GRATAMA JW
EGGERMONT AMM
BOLHUIS RLH
STOTER G
Citation: Whj. Kruit et al., DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA, British Journal of Cancer, 74(6), 1996, pp. 951-955
Authors:
GOEY SH
GRATAMA JW
PRIMROSE JN
WARD U
MERTELSMANN RH
OSTERWALDER B
VERWEIJ J
STOTER G
Citation: Sh. Goey et al., INTERLEUKIN-2 AND INTERFERON ALPHA-2A DO NOT IMPROVE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER, British Journal of Cancer, 74(12), 1996, pp. 2018-2023